The primary objective of this clinical trial is to demonstrate the non-inferiority of the generic investigational medicinal product containing preservative-free Travoprost 40gml in comparison with the commercially available preservative-containing comparator TRAVATAN 40gml Alcon Laboratories Ltd UK in the treatment of open angle glaucoma or ocular hypertension by examining the average change of diurnal IOP measured between last visit and baseline
Data and Resources
- Therapeutic Equivalence non-inferiority Randomized Observer-blind two Parallel Group Clinical Trial for Comparing the Efficacy and Tolerability of a new Generic Formulation of Travoprost 40gml Eye Drops Free of Preservatives vs TRAVATAN 40gml Eye...json
The primary objective of this clinical trial is to demonstrate the non-...
|Release Date|| |
|Public Access Level|| |